Carlson Investments Valuation

Is 2HB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2HB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 2HB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 2HB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2HB?

Key metric: As 2HB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 2HB. This is calculated by dividing 2HB's market cap by their current revenue.
What is 2HB's PS Ratio?
PS Ratio	7.3x
Sales	zł4.82m
Market Cap	zł35.37m

2HB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.1x
Enterprise Value/EBITDA	-248.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 2HB's PS Ratio compare to its peers?

The above table shows the PS ratio for 2HB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	9.1x
SCI SCI	2.1x	n/a	€8.8m
CORE Coreo	0.5x	n/a	€7.4m
DLB DLB-Anlageservice	17.5x	n/a	€6.1m
6MP Murphy & Spitz Green Capital	16.1x	n/a	€6.1m
2HB Carlson Investments	7.3x	n/a	€35.4m

Price-To-Sales vs Peers: 2HB is good value based on its Price-To-Sales Ratio (7.3x) compared to the peer average (9.1x).

Price to Sales Ratio vs Industry

How does 2HB's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 Companies	Price / Sales	Estimated Growth	Market Cap
MLP MLP	0.6x	3.1%	US$675.15m
MUX Mutares SE KGaA	0.09x	10.5%	US$510.11m
AR4 AURELIUS Equity Opportunities SE KGaA	0.2x	0.01%	US$500.05m
AR4 AURELIUS Equity Opportunities SE KGaA	0.1x	n/a	US$409.07m

22 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 2HB is expensive based on its Price-To-Sales Ratio (7.3x) compared to the German Capital Markets industry average (2.8x).

Price to Sales Ratio vs Fair Ratio

What is 2HB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2HB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	7.3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 2HB's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Mutares SE KGaA

€467.6m

A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.

MUX

€22.15

-3.9%

-28.7%

Exor

€20.2b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€94.55

0.3%

9.2%

Merchants Bancorp

US$1.8b

Operates as the diversified bank holding company in the United States.

3KD

US$36.60

-5.2%

18.8%